Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood
/in Esophageal Carcinoma, International Publications /von 2005-08-18 / Vaccine 2005 Nov;23(45):5225-30First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
/in Cervical Cancer, International Publications /von 2005-08-15 / Cancer 2005 Aug;104(4):763-70Immunotherapy in multiple myeloma–possibility or probability?
/in International Publications, Malignant Lymphoma /von 2005-08-01 / Br. J. Haematol. 2005 Aug;130(3):344-62Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
/in International Publications, Newcastle Disease Virus /von 2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-84Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma
/in Gallbladder Cancer, International Publications /von 2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de